Cited by 12Inflammatory Bowel DiseaseGenetic Associations and EpidemiologyOcular Diseases and Behçet’s Syndrome

An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis

Open access
Mortlock, Sally, Lord, Anton, Montgomery, Grant, Zakrzewski, Martha, Simms, Lisa A, Krishnaprasad, Krupa, Hanigan, Katherine, Doecke, James D +12 more·2023·Journal of Crohn's and Colitis

Published version of a preprint

Abstract

Background and Aims: Ulcerative colitis [UC] is a major form of inflammatory bowel disease globally. Phenotypic heterogeneity is defined by several variables including age of onset and disease extent. The genetics of disease severity remains poorly understood. To further investigate this, we performed a genome wide association [GWA] study using an extremes of phenotype strategy. Methods: We conducted GWA analyses in 311 patients with medically refractory UC [MRUC], 287 with non-medically refractory UC [non-MRUC] and 583 controls. Odds ratios [ORs] were calculated for known risk variants comparing MRUC and non-MRUC, and controls. Results: MRUC–control analysis had the greatest yield of genome-wide significant single nucleotide polymorphisms [SNPs] [2018], including lead SNP = rs111838972 [OR = 1.82, p = 6.28 × 10−9] near MMEL1 and a locus in the human leukocyte antigen [HLA] region [lead SNP = rs144717024, OR = 12.23, p = 1.7 × 10−19]. ORs for the lead SNPs were significantly higher in MRUC compared to non-MRUC [p < 9.0 × 10−6]. No SNPs reached significance in the non-MRUC–control analysis (top SNP, rs7680780 [OR 2.70, p = 5.56 × 10−8). We replicate findings for rs4151651 in the Complement Factor B [CFB] gene and demonstrate significant changes in CFB gene expression in active UC. Detailed HLA analyses support the strong associations with MHC II genes, particularly HLA-DQA1, HLA-DQB1 and HLA-DRB1 in MRUC. Conclusions: Our MRUC subgroup replicates multiple known UC risk variants in contrast to non-MRUC and demonstrates significant differences in effect sizes compared to those published. Non-MRUC cases demonstrate lower ORs similar to those published. Additional risk and prognostic loci may be identified by targeted recruitment of individuals with severe disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ecco-jcc/jjac121

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies indicate significant differences in SNPs associated with medically refractory ulcerative colitis compared to non-medically refractory ulcerative colitis.

    “Studies indicate significant differences in SNPs associated with MRUC compared to non- MRUC[19], but translating these findings into practical screening protocols requires further validation.”
  • Some genetic variants are linked to disease severity in ulcerative colitis.

    “Moreover, research on prognosis in UC associated with Mendelian traits suggests that while some genetic variants are linked to disease severity, such as the SNPs identified in medically refractory UC (MRUC) studies[19], a comprehensive understanding of their prognostic value in routine clinical practice is still developing.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mortlock, S., Lord, A., Montgomery, G., Zakrzewski, M., Simms, L. A., Krishnaprasad, K., Hanigan, K., Doecke, J. D., Walsh, A., Lawrance, I. C., Bampton, P. A., Andrews, J. M., Mahy, G., Connor, S. J., Sparrow, M. P., Bell, S., Florin, T. H., Begun, J., Gearry, R. B., & Radford-Smith, G. L.
Affiliations
  • The University of Queensland (AU)
  • QIMR Berghofer Medical Research Institute (AU)
  • Commonwealth Scientific and Industrial Research Organisation (AU)
  • John Radcliffe Hospital (GB)
  • St John of God Subiaco Hospital (AU)
  • Flinders Medical Centre (AU)
  • Royal Adelaide Hospital (AU)
  • Townsville Hospital (AU)
  • Liverpool Hospital (AU)
  • The Alfred Hospital (AU)
  • Monash Health (AU)
  • Translational Research Institute (AU)
  • University of Otago (NZ)
  • QIMR Berghofer Medical Research Institute , Brisbane, QLD , Australia
Venue
Journal of Crohn's and Colitis
Published
2022-09-16
Volume
17
Issue
2
Pages
277-288
ISSN
  • 1873-9946 (ISSN-L)
  • 1876-4479
OpenAlex
W4296033383
Cited by
12
References
54
Citations by year
2026: 3 · 2025: 4 · 2024: 3 · 2023: 2
FWCI
1.36
Type
journal article
Language
en
Open access
Locations
  • Journal of Crohn s and Colitis (publishedVersion, cc-by-nc)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by-nc)
  • UWA Profiles and Research Repository (UWA) (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
Funders
  • National Health and Medical Research Council (APP1028569)
  • Royal Brisbane and Women’s Hospital Foundation
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
ulcerative colitis
MeSH terms
Colitis, Ulcerative, Humans, Phenotype, Case-Control Studies, Genetic Heterogeneity, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review